Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.82	23.55	43.15	70.9	15.17	10.74
Cash & Cash Equivalents	16.82	23.55	43.15	70.9	15.17	10.74
Cash Growth	-54.85%	-45.42%	-39.15%	367.30%	41.34%	50.48%
Other Current Assets	2.13	2.72	2.45	1.59	2.03	2.75
Total Current Assets	18.96	26.27	45.6	72.5	17.2	13.48
Property, Plant & Equipment	0.74	0.8	0.68	0.45	0.69	0.6
Goodwill and Intangibles	11.15	11.15	11.15	11.15	11.15	11.15
Total Long-Term Assets	11.89	11.94	11.83	11.59	11.83	11.75
Total Assets	30.85	38.22	57.42	84.09	29.03	25.24
Accounts Payable	2.1	2.5	2.1	1.36	1.13	2.15
Other Current Liabilities	3.3	4.32	2.72	2.26	1.79	1.42
Total Current Liabilities	5.41	6.82	4.82	3.62	2.92	3.57
Long-Term Debt	0.45	0.47	0.34	0.06	0.16	0.28
Other Long-Term Liabilities	3.4	4.86	0.08	1.41	8.19	5.82
Total Long-Term Liabilities	3.85	5.33	0.41	1.48	8.35	6.09
Total Liabilities	9.26	12.14	5.23	5.1	11.27	9.66
Total Debt	0.45	0.47	0.34	0.06	0.16	0.28
Debt Growth	46.10%	41.49%	431.75%	-60.38%	-42.39%	-
Retained Earnings	-136.57	-131.6	-101.84	-72.81	-56.92	-39.56
Comprehensive Income	-0.02	-0.01	0.01	0.04	0.07	0.03
Shareholders' Equity	21.59	26.07	52.19	78.99	17.76	15.57
Net Cash / Debt	16.37	23.08	42.81	70.84	15.01	10.46
Net Cash / Debt Growth	-55.69%	-46.10%	-39.57%	371.83%	43.55%	46.61%
Net Cash Per Share	6.64	11.68	22.45	39.54	22.87	23.12
Working Capital	13.55	19.46	40.78	68.88	14.28	9.91
Book Value Per Share	8.75	13.20	27.37	44.09	27.06	34.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).